Skip to main content
. 2023 Jan 13;4(4):241–250. doi: 10.1016/j.hroo.2023.01.001

Figure 2.

Figure 2

Association between late gadolinium enhancement (LGE) and mortality. LGE was associated with an increased risk of all-cause mortality (odds ratio 2.9; 95% confidence interval [CI] 2.3–3.8; P < .01). There was low heterogeneity (χ232 = 51.26; P = .017; I2 = 37%).